The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering

Biomaterials

Volumn 32, Issue 32, 2011, Pages 8129-8138

  Wong, Maelene L ^a,b   Leach, J Kent ^a   Athanasiou, Kyriacos A ^a   Griffiths, Leigh G ^b  

^a University of California Davis   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen removal; Decellularization; Extracellular matrix; Heart valve tissue engineering; Xenogeneic scaffold

Indexed keywords

ANTIGENICITY; AR METHOD; BOVINE PERICARDIUM; CELL NUCLEUS; DECELLULARIZATION; EXTRACELLULAR MATRICES; FUNCTIONAL PROPERTIES; HEART VALVE TISSUE ENGINEERING; HEART VALVES; IMMUNE RESPONSE; PROMOTING PROTEIN; PROTEIN ANTIGENS; PROTEIN SOLUBILITY; REGENERATIVE MEDICINE; TISSUE ENGINEERING SCAFFOLD; XENOGENEIC SCAFFOLD;

ANTIGENS; BIOMATERIALS; ENGINEERING; ENZYME ACTIVITY; HEART; PROTEINS; SOLUBILITY; TISSUE;

SCAFFOLDS (BIOLOGY);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN REMOVAL; ANTIGEN RETRIEVAL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART VALVE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SOLUBILIZATION; SOLUBILIZATION; TENSILE STRENGTH; TISSUE ENGINEERING; XENOGRAFT;

ANIMALS; ANTIGENS; BLOTTING, WESTERN; BUFFERS; CATTLE; DITHIOTHREITOL; HEART VALVE PROSTHESIS; PERICARDIUM; POTASSIUM CHLORIDE; PROTEINS; SOLUBILITY; TENSILE STRENGTH; TISSUE ENGINEERING;

BOVINAE;

EID: 80052385104     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.030     Document Type: Article

References (41)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-171.
2. Human P., Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001, 71:S385-S388.
3. Manji R.A., Zhu L.F., Nijjar N.K., Rayner D.C., Korbutt G.S., Churchill T.A., et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006, 114:318-327.
4. Shinoka T., Breuer C., Tanel R., Zund G., Miura T., Ma P., et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995, 60:S513-S516.
5. Sacks M.S., Schoen F.J., Mayer J.E. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 2009, 11:289-313.
6. Mendelson K., Schoen F. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006, 34:1799-1819.
7. Schmidt C.E., Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000, 21:2215-2231.
8. Yang M., Chen C.-Z., Wang X.-N., Zhu Y.-B., Gu Y.J. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater 2009, 91B:354-361.
9. Mirsadraee S., Wilcox H.E., Korossis S.A., Kearney J.N., Watterson K.G., Fisher J., et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 2006, 12:763-773.
10. Goncalves A.C., Griffiths L.G., Anthony R.V., Orton E.C. Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. J Heart Valve Dis 2005, 14:212-217.
11. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT(TM) in pediatric patients. Eur J Cardiothorac Surg 2003, 23:1002-1006.
12. Rieder E., Seebacher G., Kasimir M.-T., Eichmair E., Winter B., Dekan B., et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005, 111:2792-2797.
13. Kasimir M., Rieder E., Seebacher G., Nigisch A., Dekan B., Wolner E., et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 2006, 15:278-286.
14. Wilhelmi M., Rebe P., Leyh R., Wilhelmi M., Haverich A., Mertsching H. Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep. Int J Artif Organs 2003, 26:411-420.
15. Bastian F., Stelzmüller M.-E., Kratochwill K., Kasimir M.-T., Simon P., Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 2008, 29:1824-1832.
16. Kasimir M.T., Rieder E., Seebacher G., Wolner E., Weigel G., Simon P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 2005, 11:1274-1280.
17. Shaw M.M., Riederer B.M. Sample preparation for two-dimensional gel electrophoresis. Proteomics 2003, 3:1408-1417.
18. Herbert B.R., Molloy M.P., Gooley A.A., Walsh B.J., Bryson W.G., Williams K.L. Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent. Electrophoresis 1998, 19:845-851.
19. Weiss W., Görg A. Protein solubilization. Proteomics sample preparation 2008, 135-137. Wiley-VCH, Weinheim. J. Hagen (Ed.).
20. Rabilloud T. Protein solubility in two-dimensional electrophoresis. The protein protocols handbook 2002, 131-140. Humana Press, Totowa. J.M. Walker (Ed.).
21. Koolman J., Roehm K.-H. Isolation and analysis of proteins. Color atlas of biochemistry 2005, Thieme, Stuttgart and New York, p. 78-79. 2nd ed.
22. Upreti G.C., Davis C., Oliver J. Preparation of representative homogenates of biological tissues: effect of salt on protein extraction. Anal Biochem 1991, 198:298-301.
23. Griffiths L.G., Choe L., Lee K.H., Reardon K.F., Orton E.C. Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue. Electrophoresis 2008, 29:4508-4515.
24. Griffiths L.G., Choe L.H., Reardon K.F., Dow S.W., Christopher Orton E. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials 2008, 29:3514-3520.
25. Guide for the care and use of laboratory animals 1996, National Research Council. Institute of Laboratory Animal Resources Commission on Life Sciences, National Academy Press, Washington DC.
26. Sanchez D.M., Gaitan D.M., Leon A.F., Mugnier J., Briceno J.C. Fixation of vascular grafts with increased glutaraldehyde concentration enhances mechanical properties without increasing calcification. ASAIO J 2007, 53:257-262.
27. Ling Y. Uniaxial true stress-strain after necking. AMP J Tech 1996, 5:37-48.
28. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961, 93:440-447.
29. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27:3675-3683.
30. Masutani H., Ueda S., Yodoi J. The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 2005, 12:991-998.
31. De Bernardez Clark E. Refolding of recombinant proteins. Curr Opin Biotechnol 1998, 9:157-163.
32. Roussel A., Cohen N., Holland P., Taliaoferro L., Green R., Benson P., et al. Alterations in acid-base balance and serum electrolyte concentrations in cattle: 632 cases (1984-1994). J Am Vet Med Assoc 1998, 212:1769-1775.
33. Merryman W.D., Engelmayr J.G.C., Liao J., Sacks M.S. Defining biomechanical endpoints for tissue engineered heart valve leaflets from native leaflet properties. Prog Ped Card 2006, 21:153-160.
34. Thubrikar M. The aortic valve 1990, CRC Press, Inc;, Boca Raton.
35. Vesely I. The role of elastin in aortic valve mechanics. J Biomech 1997, 31:115-123.
36. Stradins P., Lacis R., Ozolanta I., Purina B., Ose V., Feldmane L., et al. Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg 2004, 26:634-639.
37. O'Brien M., Goldstein S., Walsh S., Black K., Elkins R., Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999, 11:194-200.
38. Kasimir M.T., Rieder E., Seebacher G., Silberhumer G., Wolner E., Weigel G., et al. Comparison of different decellularization procedures of procine heart valves. Int J Artif Organs 2003, 26:421-427.
39. Schenke-Layland K., Vasilevski O., Opitz F., König K., Riemann I., Halbhuber K.J., et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003, 143:201-208.
40. Stavnezer J., Guikema J.E.J., Schrader C.E. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008, 26:261-292.
41. Meyer S.R., Chiu B., Churchill T.A., Zhu L., Lakey J.R.T., Ross D.B. Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A 2006, 79A:254-262.